Public Profile

Serono Ltd.

Serono Ltd., a prominent player in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 1906, the company has a rich history marked by significant milestones, including its pioneering work in reproductive health and neurology. Specialising in innovative therapies, Serono is renowned for its unique offerings in areas such as multiple sclerosis and fertility treatments. Their commitment to research and development has positioned them as leaders in the biopharmaceutical industry, with a strong focus on patient-centric solutions. With a robust portfolio of core products, Serono Ltd. continues to achieve notable success, solidifying its market position as a trusted provider of advanced medical therapies. The company’s dedication to improving patient outcomes underscores its reputation as a forward-thinking organisation in the ever-evolving healthcare landscape.

DitchCarbon Score

How does Serono Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Serono Ltd.'s score of 32 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

46%

Let us know if this data was useful to you

Serono Ltd.'s reported carbon emissions

Serono Ltd., headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in industry-standard climate commitments, which may include initiatives aimed at reducing environmental impact and enhancing sustainability practices. As the landscape of corporate climate action evolves, it is essential for companies like Serono Ltd. to establish measurable targets and transparent reporting to contribute effectively to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Serono Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Serono Ltd. is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Serono Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Shire-NPS Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 6 days ago
DitchCarbon Score

Emmaus Life Sciences, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Shire plc

IE
Health and social work services (85)
Updated 1 day ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers